TRAVERSA SERGIO Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$967,657.29
Insider Sells Quantity
14
Insider Sells Sum
$1.8M

Insider Activity of TRAVERSA SERGIO

According to the SEC Form 4 filings, TRAVERSA SERGIO, being in a position of

  1. Chief Executive Officer at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 500000 shares for $1.54M, and sold 0 shares,
    over all time since 2015-12-14, has bought 1430226 shares for $2.85M, and sold 54068 shares for $1.8M.

Biography of TRAVERSA SERGIO

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,540,8004100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
100,000
0.096%
$4.10$410,000-12.9%
2026-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
100,000
0.0974%
$4.18$418,000-12.47%
2025-12-15PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
27,500
0.0355%
$4.12$113,300+9.75%
2025-11-05PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
272,500
0.7992%
$2.20$599,500+81.27%
2025-08-28PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
55,976
0.161%
$0.74$41,422+485.81%
2025-08-27PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
129,455
0.3903%
$0.67$86,735+578.12%
2025-08-26PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
80,545
0.24%
$0.62$49,938+586.42%
2025-05-20PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
147,686
0.4151%
$0.56$82,246+523.12%
2025-05-19PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
30,000
0.0888%
$0.50$14,994+617.09%
2025-05-16PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
172,314
0.5063%
$0.45$77,472+685.25%
2024-09-11PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
51,407
0.1813%
$2.99$153,707-19.99%
2024-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
33,014
0.1071%
$2.75$90,789-14.01%
2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
55,579
0.1789%
$2.71$150,619-13.39%
2024-01-31PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
27,460
0.0923%
$4.00$109,752-15.27%
2024-01-30PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
40,999
0.1345%
$3.90$159,949-16.08%
2024-01-29PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
31,541
0.1037%
$3.71$117,036-9.95%
2022-12-08PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
55,250
0.1801%
$2.10$115,804+37.79%
2022-06-30SaleRelmada Therapeutics, Inc.
RLMD
Chief Executive Officer
4,068
0.0131%
$18.32$74,526-73.16%
2021-03-10SaleRelmada Therapeutics, Inc.
RLMD
CEO
2,983
0.0181%
$35.09$104,676-27.12%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
CEO
7,017
0.0434%
$35.65$250,169-27.01%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.